The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trabectedin in advanced retroperitoneal well differentiated/dedifferentiated liposarcoma and leiomyosarcoma (TRAVELL): Results of a phase 2 study from Italian sarcoma group (ISG).
 
Roberta Sanfilippo
Honoraria - PharmaMar
Consulting or Advisory Role - PharmaMar
Research Funding - Advenchen Laboratories (Inst); Amgen/Dompé (Inst); Arog (Inst); Bayer (Inst); Blueprint Medicines (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Eisai (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
 
Giovanni Grignani
Honoraria - Bayer; Eisai; GlaxoSmithKline; Lilly; Merck Serono; Novartis; Pfizer; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Eisai; GlaxoSmithKline; Merck; PharmaMar
Speakers' Bureau - GlaxoSmithKline; GlaxoSmithKline
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar; tesaro
 
Chiara Fabbroni
Research Funding - Advenchen Laboratories (Inst); Amgen/Dompé (Inst); Arog (Inst); Bayer (Inst); Blueprint Medicines (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Eisai (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
 
Bruno Vincenzi
Consulting or Advisory Role - abbott; GlaxoSmithKline; Lilly
Speakers' Bureau - PharmaMar
Research Funding - BD Bard
 
Elena Fumagalli
Research Funding - PharmaMar (Inst)
 
Tommaso Martino De Pas
Research Funding - Pfizer (Inst)
 
Alessandro Mazzocca
No Relationships to Disclose
 
Toni Ibrahim
Consulting or Advisory Role - Amgen; PharmaMar
Travel, Accommodations, Expenses - Pharmamar
 
Maria A. Pantaleo
No Relationships to Disclose
 
Antonella Brunello
Consulting or Advisory Role - Eisai; GlaxoSmithKline; PharmaMar
Travel, Accommodations, Expenses - PharmaMar; Takeda
 
Giacomo Giulio Baldi
No Relationships to Disclose
 
Antonella Boglione
No Relationships to Disclose
 
Sonia Fatigoni
Travel, Accommodations, Expenses - Ipsen; Janssen; Pharmamar
 
Andrea Marrari
No Relationships to Disclose
 
Alfredo Berruti
Consulting or Advisory Role - Amgen; Astellas Pharma; Janssen-Cilag
Speakers' Bureau - Astellas Pharma; Janssen-Cilag
Research Funding - Astellas Pharma (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Sanofi; Sanofi
 
Monica Giordano
No Relationships to Disclose
 
Angelo Paolo Dei Tos
Honoraria - PharmaMar
Consulting or Advisory Role - PharmaMar
 
Luciano Carlucci
No Relationships to Disclose
 
Eliana Rulli
No Relationships to Disclose
 
Paolo Giovanni Casali
Research Funding - Advenchen Laboratories (Inst); Amgen/Dompé (Inst); Arog (Inst); Bayer (Inst); Blueprint Medicines (Inst); Daiihi Sankyo (Inst); Deciphera (Inst); Eisai (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)